Research Trends, Collaborations, and Impact of Curcuma sp. as a Colorectal Cancer Drug: A Bibliometric Review (2003-2023)

¹ Doctoral Program, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
² Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia

^* Corresponding author: nugroho_ae@ugm.ac.id

Abstract

Colorectal cancer ranks as the third most prevalent cancer, was the second most common cause of cancer-related deaths globally. Nowadays, plenty of papers are published about Curcuma sp. as colorectal cancer; however, no bibliometric study about the topic exists. This study examines the existing papers about Curcuma sp. as colorectal cancer agent using bibliometric analysis focusing on countries, institutions, publishers, authors, documents, and keywords. Bibliographic information of relevant research articles were obtained from the Scopus database. This research presents a detailed bibliometric analysis of scientific publications from 2003 to 2023. In total, 121 documents from 95 journals, it was found that production has grown steadily, with an annual growth rate of 5.65%. The average number of citations per document is 65.02, indicating a significant impact on the scientific community. This analysis highlights the most productive authors, the most frequently cited papers, and the key geographic regions that drive scientific output. This study explains the role of Curcuma sp. in the fight against colorectal cancer. It includes descriptions of molecular mechanisms, pre-clinical testing, clinical trials, and the effectiveness of alternative therapies. The study highlights the ongoing significance of this topic over time, illustrating the transition from basic research to clinical applications.